Next Article in Journal
Nitrogen Sources and Iron Availability Affect Pigment Biosynthesis and Nutrient Consumption in Anabaena sp. UTEX 2576
Next Article in Special Issue
Interconnections between the Oral and Gut Microbiomes: Reversal of Microbial Dysbiosis and the Balance between Systemic Health and Disease
Previous Article in Journal
Pseudodesulfovibrio cashew sp. Nov., a Novel Deep-Sea Sulfate-Reducing Bacterium, Linking Heavy Metal Resistance and Sulfur Cycle
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

Deep Ultraviolet Light-Emitting Diode Light Therapy for Fusobacterium nucleatum

1
Department of Laboratory Science, Graduate School of Medicine, Yamaguchi University, Ube 7558505, Japan
2
Department of Gastroenterology and Hepatology, Graduate School of Medicine, Yamaguchi University, Ube 7558505, Japan
3
Department of Oral and Maxillofacial Surgery, Graduate School of Medicine, Yamaguchi University, Ube 7558505, Japan
4
Department of Oncology and Laboratory Medicine, Graduate School of Medicine, Yamaguchi University, Ube 7558505, Japan
*
Author to whom correspondence should be addressed.
These authors equally contributed to this work.
Microorganisms 2021, 9(2), 430; https://doi.org/10.3390/microorganisms9020430
Submission received: 23 January 2021 / Revised: 9 February 2021 / Accepted: 15 February 2021 / Published: 19 February 2021

Abstract

:
Background: Fusobacterium nucleatum, which is associated with periodontitis and gingivitis, has been detected in colorectal cancer (CRC). Methods: We evaluated the bactericidal effect of deep ultraviolet (DUV) light-emitting diode (LED) light therapy on F. nucleatum both qualitatively and quantitatively. Two DUV-LEDs with peak wavelengths of 265 and 280-nm were used. DNA damage to F. nucleatum was evaluated by the production of cyclobutane pyrimidine dimers (CPD) and pyrimidine (6–4) pyrimidone photoproducts (6–4PP). Results: DUV-LEDs showed a bactericidal effect on F. nucleatum. No colony growth was observed after 3 min of either 265 nm or 280 nm DUV-LED irradiation. The survival rates of F. nucleatum under 265 nm DUV-LED light irradiation dropped to 0.0014% for 10 s and to 0% for 20 s irradiation. Similarly, the survival rate of F. nucleatum under 280 nm DUV-LED light irradiation dropped to 0.00044% for 10 s and 0% for 20 s irradiation. The irradiance at the distance of 35 mm from the DUV-LED was 0.265 mW/cm2 for the 265 nm LED and 0.415 mW/cm2 for the 280 nm LED. Thus, the radiant energy for lethality was 5.3 mJ/cm2 for the 265 nm LED and 8.3 mJ/cm2 for the 280 nm LED. Amounts of CPD and 6–4PP in F. nucleatum irradiated with 265 nm DUV-LED light were 6.548 ng/µg and 1.333 ng/µg, respectively. Conclusions: DUV-LED light exerted a bactericidal effect on F. nucleatum by causing the formation of pyrimidine dimers indicative of DNA damage. Thus, DUV-LED light therapy may have the potential to prevent CRC.

1. Introduction

The development of gastrointestinal cancer involves lifestyle factors such as alcohol use, smoking [1], obesity [2], and eating habits [3] as well as certain infectious diseases [4]. The International Agency for Research Cancer (IARC) identified Helicobacter pylori as a definite oncogenic factor for gastric cancer from epidemiological studies in 1994 [5], and eradication therapy for H. pylori has been shown to suppress the development of metachronous gastric cancers [6,7]. Unlike gastric cancer, the mortality rate from colorectal cancer (CRC) has increased significantly in Japan, and thus effective methods to prevent CRC are required.
Gut dysbiosis has been associated with the development of CRC [8]. Recent studies have identified Fusobacterium nucleatum (F. nucleatum), Streptococcus bovis, enterotoxigenic Bacteroides fragilis, Enterococcus faecalis, Escherichia coli, and Peptostreptococcus anaerobius as CRC candidate pathogens [9]. F. nucleatum has been reported to be detected in CRC [10]. Fusobacterium is an anaerobic Gram-negative bacillus present in the oral cavity and digestive tract of healthy individuals [11], and F. nucleatum is associated with oral inflammatory diseases such as periodontitis and gingivitis [12,13,14]. In 2012, Kostic et al. characterized the composition of the microbiota in colorectal carcinoma using whole genome sequencing and showed that Fusobacterium sequences were enriched in carcinomas [15]. Castellarin et al. also found that only F. nucleatum was significantly increased in CRC tumors relative to control specimens by using RNA sequencing [16]. Mima et al. reported that the amount of F. nucleatum DNA in CRC tissue is associated with shorter survival [17], and Yamaoka et al. found that it may potentially serve as a prognostic biomarker [18]. Thus, accumulating evidence suggests that F. nucleatum is associated with the development and progression of CRC in humans.
Several studies have revealed a mechanism by which F. nucleatum contributes to CRC development. Rubinstein et al. showed that FadA adhesin on F. nucleatum binds to E-cadherin and activates β-catenin signaling in CRC cells, and then, CRC growth is induced by transcription of c-Myc and cyclin-D1 [19]. Yang et al. showed that CRC cell lines infected with F. nucleatum formed larger tumors more rapidly in nude mice than did uninfected cells. Infection of cells with F. nucleatum increased the expression of miR21 by activating TLR4 signaling to MYD88, leading to the activation of nuclear factor NFκB [20]. Yu et al. found that F. nucleatum was abundant in CRC tissues of patients with recurrence after chemotherapy. F. nucleatum targeted TLR4 and MYD88 innate immune signaling and specific microRNAs to activate the autophagy pathway and alter CRC chemotherapeutic response [21]. Gur et al. found that the Fap2 protein of F. nucleatum directly interacted with T-cell immunoglobulin and the ITIM domain (TIGIT), leading to the inhibition of NK cell cytotoxicity [22]. F. nucleatum adheres to and invades CRC cells and then induces oncogenic and inflammatory responses to stimulate their growth.
We have considered deep ultraviolet (DUV) light-emitting diode (LED) light therapy for the treatment of F. nucleatum. Because F. nucleatum forms a biofilm in the periodontal pocket, injection of an antibacterial agent does not provide a sufficient bactericidal effect, and infection often recurs [23]. LEDs are semiconductor devices that emit light and are ideal for downsizing equipment [24]. Recently, LEDs that can emit ultraviolet light have been developed [25], and we have confirmed that DUV-LEDs have various bactericidal effects against bacteria and fungi in vitro [26]. In the present study, the bactericidal effect of DUV-LEDs on F. nucleatum was examined.

2. Materials and Methods

2.1. Fusobacterium nucleatum Strain and Growth Conditions

F. nucleatum (ATCC 25586) and Escherichia coli (NBRC3972) were purchased from NITE Biological Resource Center (NBRC). The frozen bacterial stock of F. nucleatum was cultivated in Gifu Anaerobic Medium (GAM) agar in an anaeropack at 37 °C for 72 h. E. coli were cultured on heart infusion agar (Eiken Kagaku Co., Ltd., Tokyo, Japan) at 37 °C for 16 h. Then, cell suspensions were prepared using phosphate-buffered saline (PBS).

2.2. Irradiation by DUV-LEDs

Two DUV-LEDs with peak wavelengths of 265 and 280-nm (VPS131 (265-nm LED) and VPS161 (280-nm LED), NIKKISO CO., LTD., Tokyo, Japan) were used (Figure 1). Total radiant flux of the DUV-LEDs was 9.4 mW for the 265 nm and 17.0 mW for the 280 nm wavelength. As the half-power angle of the LEDs was 130 degrees, we set the distance between the LED and the plate at 35 mm, which enabled uniform DUV-LED illumination (Figure 2). The rated current for the 265 nm LEDs set by the company is 350 mA. We used a direct current-regulated power supply in constant current mode (PW36-1.5AD, TEXIO TECHNOLOGY CORPORATION, Yokohama, Japan). The current was set to 350 mA or 50 mA to irradiate LED light. Irradiance was measured with an MCPD-9800 array spectrometer (Otsuka Electronics, Osaka, Japan).

2.3. Qualitative Test of Bactericidal Effect on Agar Medium Surface by DUV-LED Light

The suspension of F. nucleatum was adjusted to 1 McFarland turbidity standard with PBS and then spread on GAM agar plates (diameter, 35 mm) with a cotton swab. We conducted time series tests with irradiation times of 0, 10, 20, 30, 60, and 180 s. Colonies of F. nucleatum were observed after anaerobic cultivation for 6 days. As the non-irradiated control, F. nucleatum was left in the air for the same time periods as the DUV-LED irradiation.

2.4. Quantitative Test of Bactericidal Effect of DUV-LED Light

Bactericidal effects were determined using a colony-forming assay. The cell suspension of F. nucleatum was adjusted to 1.0 × 106 colony forming units (CFU)/mL. One milliliter of cell suspension was dispensed onto a 35 mm dish and irradiated by DUV-LED light. We conducted time series tests with irradiation times of 0, 10, 20, and 30 s. Then, 10 μL of 10-fold serial dilutions of the cell suspension was plated onto GAM agar in quadruplicate, and the plates were incubated at 37 °C for 6 days. Thereafter, the number of colonies was counted, and survival rate was expressed as a percentage of the non-irradiated control. The experiment was performed three times, and the average percentage of surviving F. nucleatum was evaluated [27,28].

2.5. Cytotoxicity of Human Keratinocytes by DUV-LED

HaCaT cells, a spontaneously immortalized human keratinocyte line, were cultured in Dulbecco’s Modified Eagle Medium—high glucose (4.5 g/L) with L-glutamine and with sodium pyruvate (Capricorn) supplemented with 10% fetal bovine serum. HaCaT cells (4.0 × 105/dish) were seeded in 35 mm dishes and cultured at 37 °C in 5% CO2 for 24 h. The cells were then washed twice with PBS, after which we immediately irradiated the cells with DUV-LED light. Two milliliters of fresh medium was added, and the mixture was cultured for 24 h. Then, the cells were harvested, and cell viability was evaluated by trypan blue dye exclusion assay. The number of viable cells was counted, and the survival rate was expressed as a percentage of the non-irradiated control. The experiment was performed three times, and the average percentage of surviving HaCaT cells was evaluated.

2.6. CPD and 6–4PP Quantification by ELISA

The DNA damage in F. nucleatum was evaluated based on the production of cyclobutane pyrimidine dimers (CPD) and pyrimidine (6–4) pyrimidone photoproducts (6–4PP) with an OxiSelect™ UV-Induced DNA Damage ELISA Kit (CELL BIOLABS Inc., San Diego, CA, USA). The bacterial suspension was adjusted to a 2 McFarland turbidity standard. Then, 2 mL of the suspension was dispensed onto a 35 mm dish, followed by DUV-LED light irradiation for 30 s. DNA was extracted from 1.8 mL of the bacterial solutions with a QIAamp DNA FFPE Tissue Kit (QIAGEN, Venlo, The Netherlands). The ELISA procedure was performed according to the manufacturer’s protocol. We used DNA samples from E. coli irradiated by DUV from a UV lamp as a positive control and DNA samples from F. nucleatum cultured without DUV irradiation as a negative control. The UV lamp (GL-15, Toshiba, Japan) was installed in a safety cabinet (Panasonic Healthcare, Tokyo, Japan).

2.7. Statistics

Differences in survival rates between the 265 nm DUV-LED and 280 nm DUV-LED were analyzed by t-test using StatFlex Ver.6.0 (Artech Co., Ltd., Osaka, Japan).

3. Results

3.1. Qualitative Test of Bactericidal Effect on Agar Medium Surface by DUV-LED Light

DUV-LEDs with peak wavelengths of 265 and 280-nm showed similar bactericidal effect on F. nucleatum cultured on an agar medium surface in a time-dependent manner. No colony growth was observed after 180 s of either 265 nm or 280 nm DUV-LED irradiation (Figure 3). In this experiment, even if the sterilized dish was returned to the culture, no bacterial growth was observed. We confirmed that an increase in the ambient temperature was not observed when we supplied a current of 350 mA to the DUV-LEDs.

3.2. Quantitative Test of Bactericidal Effect by DUV-LED Light

When we supplied a current of 350 mA to the DUV-LED, the survival rate of F. nucleatum under 265 nm DUV-LED light irradiation dropped to 0.0014% for 10 s and to 0% (below limit of detection) for 20 s irradiation. Similarly, the survival rate of F. nucleatum under 280 nm DUV-LED light irradiation dropped to 0.00044% for 10 s and 0% (below limit of detection) for 20 s irradiation (Figure 4). When 50 mA was supplied to the DUV-LED, the survival rates of F. nucleatum under 265 nm DUV-LED light irradiation were 45.34% for 10 s and 16.13% for 20 s irradiation. Whereas those of F. nucleatum under 280 nm DUV-LED light irradiation were 54.72% for 10 s and 21.34% for 20 s irradiation (Figure 4). There was no significant difference in the survival rates of F. nucleatum between the 265 nm DUV-LED and 280 nm DUV-LED irradiations. To confirm the presence of any surviving bacteria, 0.5 mL of these residual suspensions was cultured in liquid medium, but no F. nucleatum growth was observed.
When we supplied a current of 350 mA to the DUV-LED, the irradiance at the distance of 35 mm from the DUV-LED was 0.265 mW/cm2 for the 265 nm LED and 0.415 mW/cm2 for the 280 nm LED. The irradiation time under 265 nm and 280 nm DUV-LED light for which the survival rates were 0% was 20 s. Thus, the radiant energy for lethality was 5.3 mJ/cm2 for the 265 nm LED and 8.3 mJ/cm2 for the 280 nm LED.

3.3. Evaluation of HaCaT Cell Damage by DUV-LED Light

When we supplied a current of 350 mA to the DUV-LED, the survival rates of HaCaT cells under 265 nm DUV-LED light irradiation were 4.38% for 10 s and 2.08% for 20 s irradiation. Similarly, the survival rates of HaCaT cells under 280 nm DUV-LED light irradiation dropped to 3.31% for 10 s and 2.26% for 20 s irradiation (Figure 5). When 50 mA was supplied to the DUV-LED, the survival rates of HaCaT cells under 265 nm DUV-LED light irradiation were 90.14% for 10 s and 48.29% for 20 s irradiation, whereas those of HaCaT cells under 280 nm DUV-LED light irradiation were 90.06% for 10 s and 47.76% for 20 s irradiation (Figure 5). There was no significant difference in the survival rates of HaCaT cells between the 265 nm and 280 nm DUV-LED irradiations.

3.4. Detection of DUV-LED Light-Induced DNA Damage by Formation of CPD and 6–4PP

CPD and 6–4PP were detected by ELISA in the DNA samples from F. nucleatum irradiated with DUV-LED light. The respective amounts of CPD and 6–4PP in F. nucleatum irradiated with 265 nm DUV-LED were 6.548 ng/µg and 1.333 ng/µg, whereas those in F. nucleatum irradiated with 280 nm DUV-LED were 7.963 ng/µg and 1.593 ng/µg. As a control, we prepared E. coli irradiated with the UV lamp. The respective amounts of CPD and 6–4PP in the E. coli were 2.622 ng/µg and 0.276 ng/µg (Figure 6).

4. Discussion

Light irradiation from DUV-LEDs exerted a bactericidal effect on F. nucleatum in a time-dependent manner. We previously reported that the Gram-negative bacteria Pseudomonas aeruginosa and E. coli were highly sensitive to DUV-LED light [28]. F. nucleatum is an anaerobic Gram-negative bacterium with a similar sensitivity to DUV-LED as that of other Gram-negative bacteria because their cell wall is thinner than that of Gram-positive bacteria [29]. That we did not conduct experiments to form biofilms in vitro is a limitation of the present study.
DUV light at a wavelength of around 260 nm is absorbed by DNA [30]. When cells are irradiated with UV light, covalent bonds of the pyrimidine base form with the adjacent thymine or cytosine base that result in the creation of pyrimidine dimers. These dimers interfere with DNA replication and transcription that can lead to cell death, mutation, and chromosomal instability [31]. The mechanism of the bactericidal effect exerted by DUV-LEDs is thought to be due to DNA damage because DNA extracted from DUV-LED-irradiated F. nucleatum contains pyrimidine dimers. While the light wavelength around 280 nm is absorbed by proteins, the effect on proteins of cell membranes is one of the issues being pursued.
Although fusobacteria are found in CRC [10,15,16,17,18], the mechanisms by which they hone in on and localize to CRC have been underexplored. Abed et al. suggested that fusobacterial Fap2 and host Gal-GalNAc are involved in fusobacterial CRC localization and enrichment. They showed that intravenously injected F. nucleatum localizes to mouse tumor tissues in a Fap2-dependent manner, suggesting that fusobacteria use a hematogenous route to reach colon adenocarcinomas [32]. Komiya et al. reported that 75% (6/8) of CRC patients exhibited identical strains of F. nucleatum in their CRC and saliva specimens [33]. In addition, transient bacteremia is common during periodontal disease with bacterial loads reaching 104 bacteria/mL blood 15 min after tooth brushing in humans [34]. These findings suggest that F. nucleatum in CRC originates in the oral cavity. We think that sterilizing F. nucleatum in the oral cavity by DUV-LED light may reduce the number of F. nucleatum in the intestine and could potentially lead to the prevention of CRC. In addition, we previously showed that stage IV CRC patients with a high F. nucleatum copy number had a significantly shorter overall survival time than those with a low copy number [18], indicating that DUV-LED therapy may also improve survival in patients with advanced CRC.
DNA damage by DUV is elicited not only in microorganisms but also in human cells, and chronic exposure to DUV light has been established as a human health hazard [35]. In a mouse model, significant hyperplasia and intercellular edema were induced in the epidermis after chronic irradiation of 254 nm DUV at 4500 mJ/cm2 [36]. The radiant energy required for lethality of F. nucleatum in the present study was much less, 5.3 mJ/cm2 for the 265 nm LED and 8.3 mJ/cm2 for the 280 nm LED. By reducing the current supplied to the LEDs, the survival rate of HaCaT cells increased. We must first determine appropriate doses of DUV that can selectively inactivate F. nucleatum in an animal model.
DUV-LED light therapy is not a specific treatment targeting one pathogen such as vaccines do, so it may disturb the oral bacterial flora. Treatments that affect all oral bacteria can lead to nitric oxide pathways and adversely affect blood pressure regulation [37]. Thus, we must be aware of these adverse events. In the case of general oral care, however, the number of bacteria is reduced by 60 to 70%, but this is effective in preventing aspiration pneumonia [38]. Consequently, it is considered clinically useful to reduce multiple types of bacteria as a whole rather than suppressing just one type of bacteria. We believe that this also needs to be verified by animal experiments.
LEDs have unique characteristics of compactness, durability, and low heat production, and thus, DUV-LEDs can be applied in narrow spaces such the oral cavity. A mouthpiece-type phototherapy device should be considered as an effective application to irradiate DUV-LED light to a localized infection. It might be necessary to use a thin fiber to irradiate DUV into the periodontal pockets.

5. Conclusions

Irradiation with DUV-LED light exerted a bactericidal effect on F. nucleatum by causing the formation of pyrimidine dimers indicative of DNA damage. DUV-LED devices can be useful tools for the inactivation of F. nucleatum. Thus, DUV-LED light therapy may have the potential to prevent CRC.

Author Contributions

J.N. (Jun Nishikawa) and T.Y. conceived and designed the study. S.F., S.I., T.T., and N.K. acquired the data. K.-i.O., H.T., J.N. (Junzo Nojima), and K.H. analyzed the data. K.M., Y.S., and I.S. revised the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported by AMED under Grant Number JP19lm0203008.

Data Availability Statement

All data generated or analyzed during the study are included in this published article.

Conflicts of Interest

The authors declare that they have no competing interests.

References

  1. Steevens, J.; Schouten, L.J.; Goldbohm, R.A.; van den Brandt, P.A. Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: A prospective cohort study. Gut 2010, 59, 39–48. [Google Scholar] [CrossRef] [Green Version]
  2. Aune, D.; Greenwood, D.C.; Chan, D.S.; Vieira, R.; Vieira, A.R.; Navarro Rosenblatt, D.A.; Cade, J.E.; Burley, V.J.; Norat, T. Body mass index, abdominal fatness and pancreatic cancer risk: A systematic review and non-linear dose-response meta-analysis of prospective studies. Ann. Oncol. 2012, 23, 843–852. [Google Scholar] [CrossRef] [PubMed]
  3. Magalhães, B.; Peleteiro, B.; Lunet, N. Dietary patterns and colorectal cancer: Systematic review and meta-analysis. Eur. J. Cancer Prev. 2012, 21, 15–23. [Google Scholar] [CrossRef]
  4. Selgrad, M.; Malfertheiner, P.; Fini, L.; Goel, A.; Boland, C.R.; Ricciardiello, L. The role of viral and bacterial pathogens in gastrointestinal cancer. J. Cell Physiol. 2008, 216, 378–388. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Infection with Helicobacter pylori. IARC Monger Eval. Carcinog Risks Hum. 1994, 61, 177–240. [Google Scholar]
  6. Uemura, N.; Mukai, T.; Okamoto, S.; Yamaguchi, S.; Mashiba, H.; Taniyama, K.; Sasaki, N.; Haruma, K.; Sumii, K.; Kajiyama, G. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev. 1997, 6, 639–642. [Google Scholar] [CrossRef]
  7. Fukase, K.; Kato, M.; Kikuchi, S.; Inoue, K.; Uemura, N.; Okamoto, S.; Terao, S.; Amagai, K.; Hayashi, S.; Asaka, M. Japan Gast Study Group. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: An open-label, randomised controlled trial. Lancet 2008, 372, 392–397. [Google Scholar] [CrossRef] [Green Version]
  8. Chattopadhyay, I.; Dhar, R.; Pethusamy, K.; Seethy, A.; Srivastava, T.; Sah, R.; Sharma, J.; Karmakar, S. Exploring the Role of Gut Microbiome in Colon Cancer. Appl. Biochem. Biotechnol. 2021, 25. [Google Scholar] [CrossRef]
  9. Cheng, Y.; Ling, Z.; Li, L. The Intestinal Microbiota and Colorectal Cancer. Front. Immunol. 2020, 11, 615056. [Google Scholar] [CrossRef]
  10. Liu, Y.; Baba, Y.; Ishimoto, T.; Iwatsuki, M.; Hiyoshi, Y.; Miyamoto, Y.; Yoshida, N.; Wu, R.; Baba, H. Progress in characterizing the linkage between Fusobacterium nucleatum and gastrointestinal cancer. J. Gastroenterol. 2019, 54, 33–41. [Google Scholar] [CrossRef]
  11. Signat, B.; Roques, C.; Poulet, P.; Duffaut, D. Fusobacterium nucleatum in periodontal health and disease. Curr. Issues Mol. Biol. 2011, 13, 25–36. [Google Scholar] [PubMed]
  12. Yang, N.Y.; Zhang, Q.; Li, J.L.; Yang, S.H.; Shi, Q. Progression of periodontal inflammation in adolescents is associated with increased number of Porphyromonas gingivalis, Prevotella intermedia, Tannerella forsythensis, and Fusobacterium nucleatum. Int. J. Paediatr. Dent. 2014, 24, 226–233. [Google Scholar] [CrossRef] [PubMed]
  13. Kistler, J.O.; Booth, V.; Bradshaw, D.J.; Wade, W.G. Bacterial community development in experimental gingivitis. PLoS ONE 2013, 8, e71227. [Google Scholar] [CrossRef] [Green Version]
  14. Fujii, R.; Saito, Y.; Tokura, Y.; Nakagawa, K.I.; Okuda, K.; Ishihara, K. Characterization of bacterial flora in persistent apical periodontitis lesions. Oral Microbiol. Immunol. 2009, 24, 502–505. [Google Scholar] [CrossRef] [Green Version]
  15. Kostic, A.D.; Gevers, D.; Pedamallu, C.S.; Michaud, M.; Duke, F.; Earl, A.M.; Ojesina, A.I.; Jung, J.; Bass, A.J.; Tabernero, J.; et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 2012, 22, 292–298. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Castellarin, M.; Warren, R.L.; Freeman, J.D.; Dreolini, L.; Krzywinski, M.; Strauss, J.; Barnes, R.; Watson, P.; Allen-Vercoe, E.; Moore, R.A.; et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 2012, 22, 299–306. [Google Scholar] [CrossRef] [Green Version]
  17. Mima, K.; Nishihara, R.; Qian, Z.R.; Cao, Y.; Sukawa, Y.; Nowak, J.A.; Yang, J.; Dou, R.; Masugi, Y.; Song, M.; et al. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut 2016, 65, 1973–1980. [Google Scholar] [CrossRef] [Green Version]
  18. Yamaoka, Y.; Suehiro, Y.; Hashimoto, S.; Hoshida, T.; Fujimoto, M.; Watanabe, M.; Imanaga, D.; Sakai, K.; Matsumoto, T.; Nishioka, M.; et al. Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population. J. Gastroenterol. 2018, 53, 517–524. [Google Scholar] [CrossRef] [PubMed]
  19. Rubinstein, M.R.; Wang, X.; Liu, W.; Hao, Y.; Cai, G.; Han, Y.W. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin. Cell Host Microbe 2013, 14, 195–206. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  20. Yang, Y.; Weng, W.; Peng, J.; Hong, L.; Yang, L.; Toiyama, Y.; Gao, R.; Liu, M.; Yin, M.; Pan, C.; et al. Fusobacterium nucleatum increases proliferation of colorectal cancer cells and tumor development in mice by activating Toll-like receptor 4 signaling to nuclear factor-κB, and up-regulating expression of MicroRNA-21. Gastroenterology 2017, 152, 851–866. [Google Scholar] [CrossRef] [Green Version]
  21. Yu, T.; Guo, F.; Yu, Y.; Sun, T.; Ma, D.; Han, J.; Qian, Y.; Kryczek, I.; Sun, D.; Nagarsheth, N.; et al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell 2017, 170, 548–563. [Google Scholar] [CrossRef] [Green Version]
  22. Gur, C.; Ibrahim, Y.; Isaacson, B.; Yamin, R.; Abed, J.; Gamliel, M.; Enk, J.; Bar-On, Y.; Stanietsky-Kaynan, N.; Coppenhagen-Glazer, S.; et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack immunity. Immunity 2015, 42, 344–355. [Google Scholar] [CrossRef] [Green Version]
  23. Kanwar, I.; Sah, A.K.; Suresh, P.K. Biofilm-mediated antibiotic-resistant oral bacterial infections: Mechanism and combat strategies. Curr. Pharm Des. 2017, 23, 2084–2095. [Google Scholar] [CrossRef] [PubMed]
  24. Wu, C.Y.; Wu, T.F.; Tsai, J.R.; Chen, Y.M.; Chen, C.C. Multistring LED backlight driving system for LCD panels with color sequential display and area control. IEEE Trans. Ind. Electron. 2010, 55, 3791–3800. [Google Scholar]
  25. Hirayama, H.; Noguchi, N.; Yatabe, T.; Kamata, N. 227 nm AlGaN light-emitting diode with 0.15 mW output power realized using a thin quantum well and AlN buffer with reduced threading dislocation density. Appl. Phys. Express 2008, 1, 051101-3. [Google Scholar] [CrossRef]
  26. Takagi, T.; Nishikawa, J.; Yanagihara, M.; Fukuda, S.; Kubota, N.; Kobayashi, Y.; Otsuyama, K.I.; Nojima, J.; Tsuneoka, H.; Sakai, K.; et al. Microbicidal effect of deep ultraviolet light-emitting diode irradiation. Lasers Med. Sci. 2020, 9. [Google Scholar] [CrossRef]
  27. Thomas, P.; Sekhar, A.C.; Mujawar, M.M. Nonrecovery of varying proportions of viable bacteria during spread plating governed by the extent of spreader usage and proposal for an alternate spotting-spreading approach to maximize the CFU. J. Appl. Microbiol. 2012, 113, 339–350. [Google Scholar] [CrossRef] [PubMed]
  28. Okamoto, T.; Nishikawa, J.; Yanai, H.; Nakamura, H.; Takeuchi, H.; Kurai, S.; Akada, J.K.; Sakaida, I. In vitro bactericidal effects of near-ultraviolet light from light-emitting diodes on Helicobacter pylori. Scan. J. Gastroenterol. 2013, 48, 1484–1486. [Google Scholar] [CrossRef] [PubMed]
  29. Kim, D.K.; Kim, S.J.; Kang, D.H. Bactericidal effect of 266 to 279 nm wavelength UVC-LEDs for inactivation of Gram positive and Gram negative foodborne pathogenic bacteria and yeasts. Food Res. Int. 2017, 97, 280–287. [Google Scholar] [CrossRef]
  30. Tataurov, A.V.; You, Y.; Owczarzy, R. Predicting ultraviolet spectrum of single stranded and double stranded deoxyribonucleic acids. Biophys. Chem. 2008, 133, 66–70. [Google Scholar] [CrossRef] [PubMed]
  31. Sinha, R.P.; Häder, D.P. UV-induced DNA damage and repair: A review. Photochem. Photobiol. Sci. 2002, 1, 225–236. [Google Scholar] [CrossRef]
  32. Abed, J.; Emgård, J.E.; Zamir, G.; Faroja, M.; Almogy, G.; Grenov, A.; Sol, A.; Naor, R.; Pikarsky, E.; Atlan, K.A.; et al. Fap2 mediates Fusobacterium nucleatum colorectal adenocarcinoma enrichment by binding to tumor-expressed Gal-GalNAc. Cell Host Microbe 2016, 20, 215–225. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Komiya, Y.; Shimomura, Y.; Higurashi, T.; Sugi, Y.; Arimoto, J.; Umezawa, S.; Uchiyama, S.; Matsumoto, M.; Nakajima, A. Patients with colorectal cancer have identical strains of Fusobacterium nucleatum in their colorectal cancer and oral cavity. Gut 2019, 68, 1335–1337. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Ashare, A.; Stanford, C.; Hancock, P.; Stark, D.; Lilli, K.; Birrer, E.; Nymon, A.; Doerschug, K.C.; Hunninghake, G.W. Chronic liver disease impairs bacterial clearance in a human model of induced bacteremia. Clin. Transl. Sci. 2009, 2, 199–205. [Google Scholar] [CrossRef] [PubMed]
  35. American Conference of Governmental Industrial Hygienists (ACGIH®). 2017 TLVs and BEIs Book; American Conference of Governmental Industrial Hygienists (ACGIH®): Cincinnati, OH, USA, 2017; ISBN 978-1-607260-90-5. [Google Scholar]
  36. Narita, K.; Asano, K.; Morimoto, Y.; Igarashi, T.; Nakane, A. Chronic irradiation with 222-nm UVC light induces neither DNA damage nor epidermal lesions in mouse skin, even at high doses. PLoS ONE 2018, 13, e0201259. [Google Scholar] [CrossRef] [PubMed]
  37. Barbadoro, P.; Ponzio, E.; Coccia, E.; Prospero, E.; Santarelli, A.; Rappelli, G.G.L.; D’Errico, M.M. Association between hypertension, oral microbiome and salivary nitric oxide: A case-control study. Nitric Oxide 2021, 106, 66–71. [Google Scholar] [CrossRef]
  38. Yoneyama, T.; Yoshida, M.; Matsui, T.; Sasaki, H. Oral care and pneumonia. Oral Care Working Group. Lancet 1999, 354, 515. [Google Scholar] [CrossRef]
Figure 1. Spectral radiant flux of the DUV-LEDs.
Figure 1. Spectral radiant flux of the DUV-LEDs.
Microorganisms 09 00430 g001
Figure 2. The apparatus for DUV-LED irradiation. The size of the DUV-LEDs was 3.5 mm × 3.5 mm. The size of the substrate of the LEDs was 35 mm × 35 mm × 5 mm. The length of the fins of the heat sink was 32 mm.
Figure 2. The apparatus for DUV-LED irradiation. The size of the DUV-LEDs was 3.5 mm × 3.5 mm. The size of the substrate of the LEDs was 35 mm × 35 mm × 5 mm. The length of the fins of the heat sink was 32 mm.
Microorganisms 09 00430 g002
Figure 3. Qualitative test of the bactericidal effect of DUV-LED light irradiation on Fusobacterium nucleatum. (a) The growth of colonies of F. nucleatum was observed after irradiation with 265 nm LED and 280 nm LED at each time point. A non-irradiated control was used. (b) An enlarged image of the agar plates.
Figure 3. Qualitative test of the bactericidal effect of DUV-LED light irradiation on Fusobacterium nucleatum. (a) The growth of colonies of F. nucleatum was observed after irradiation with 265 nm LED and 280 nm LED at each time point. A non-irradiated control was used. (b) An enlarged image of the agar plates.
Microorganisms 09 00430 g003
Figure 4. Quantitative test of the bactericidal effect of DUV-LED light irradiation on Fusobacterium nucleatum. The survival rates of F. nucleatum after irradiation with 265 nm LED (black bars) and 280 nm LED (grey bars) are shown for the application of 350 mA or 50 mA of current. Error bars indicate standard error.
Figure 4. Quantitative test of the bactericidal effect of DUV-LED light irradiation on Fusobacterium nucleatum. The survival rates of F. nucleatum after irradiation with 265 nm LED (black bars) and 280 nm LED (grey bars) are shown for the application of 350 mA or 50 mA of current. Error bars indicate standard error.
Microorganisms 09 00430 g004
Figure 5. Evaluation of HaCaT cell damage by DUV-LED light. The survival rates of HaCaT cells after irradiation with 265 nm LED (black bars) and 280 nm LED (grey bars) are shown for the application of 350 mA or 50 mA of current. Error bars indicate standard error.
Figure 5. Evaluation of HaCaT cell damage by DUV-LED light. The survival rates of HaCaT cells after irradiation with 265 nm LED (black bars) and 280 nm LED (grey bars) are shown for the application of 350 mA or 50 mA of current. Error bars indicate standard error.
Microorganisms 09 00430 g005
Figure 6. Detection of DUV-LED light-induced DNA damage by quantification of CPD and 6–4PP with ELISA. DNA samples extracted from F. nucleatum after 30 s irradiation with 265 nm LED light (black bars) or 280 nm LED light (grey bars) were measured for amounts of CPD and 6–4PP per microgram of DNA. E. coli irradiated with a UV lamp (hatched bar) were used as a positive control.
Figure 6. Detection of DUV-LED light-induced DNA damage by quantification of CPD and 6–4PP with ELISA. DNA samples extracted from F. nucleatum after 30 s irradiation with 265 nm LED light (black bars) or 280 nm LED light (grey bars) were measured for amounts of CPD and 6–4PP per microgram of DNA. E. coli irradiated with a UV lamp (hatched bar) were used as a positive control.
Microorganisms 09 00430 g006
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Fukuda, S.; Ito, S.; Nishikawa, J.; Takagi, T.; Kubota, N.; Otsuyama, K.-i.; Tsuneoka, H.; Nojima, J.; Harada, K.; Mishima, K.; et al. Deep Ultraviolet Light-Emitting Diode Light Therapy for Fusobacterium nucleatum. Microorganisms 2021, 9, 430. https://doi.org/10.3390/microorganisms9020430

AMA Style

Fukuda S, Ito S, Nishikawa J, Takagi T, Kubota N, Otsuyama K-i, Tsuneoka H, Nojima J, Harada K, Mishima K, et al. Deep Ultraviolet Light-Emitting Diode Light Therapy for Fusobacterium nucleatum. Microorganisms. 2021; 9(2):430. https://doi.org/10.3390/microorganisms9020430

Chicago/Turabian Style

Fukuda, Soichiro, Shunsuke Ito, Jun Nishikawa, Tatsuya Takagi, Naoto Kubota, Ken-ichiro Otsuyama, Hidehiro Tsuneoka, Junzo Nojima, Koji Harada, Katsuaki Mishima, and et al. 2021. "Deep Ultraviolet Light-Emitting Diode Light Therapy for Fusobacterium nucleatum" Microorganisms 9, no. 2: 430. https://doi.org/10.3390/microorganisms9020430

APA Style

Fukuda, S., Ito, S., Nishikawa, J., Takagi, T., Kubota, N., Otsuyama, K. -i., Tsuneoka, H., Nojima, J., Harada, K., Mishima, K., Suehiro, Y., Yamasaki, T., & Sakaida, I. (2021). Deep Ultraviolet Light-Emitting Diode Light Therapy for Fusobacterium nucleatum. Microorganisms, 9(2), 430. https://doi.org/10.3390/microorganisms9020430

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop